BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 29563202)

  • 1. Next-Generation Sequencing for Characterizing Drug Resistance-Conferring Mycobacterium tuberculosis Genes from Clinical Isolates in the Ukraine.
    Daum LT; Konstantynovska OS; Solodiankin OS; Liashenko OO; Poteiko PI; Bolotin VI; Hrek II; Rohozhyn AV; Rodriguez JD; Fischer GW; Chambers JP; Gerilovych AP
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29563202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-genome sequencing of clinical isolates from tuberculosis patients in India: real-world data indicates a high proportion of pre-XDR cases.
    Bhanushali A; Atre S; Nair P; Thandaseery GA; Shah S; Kuruwa S; Zade A; Nikam C; Gomare M; Chatterjee A
    Microbiol Spectr; 2024 May; 12(5):e0277023. PubMed ID: 38597637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotyping and molecular characteristics of multidrug-resistant Mycobacterium tuberculosis isolates from China.
    Zhang Z; Lu J; Liu M; Wang Y; Qu G; Li H; Wang J; Pang Y; Liu C; Zhao Y
    J Infect; 2015 Apr; 70(4):335-45. PubMed ID: 25485999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between drug resistance of Beijing/W lineage clinical isolates of Mycobacterium tuberculosis and sublineages: a 2009-2013 prospective study in Xinjiang province, China.
    Wang XH; Ma AG; Han XX; Gu XM; Fu LP; Li PG; Li FY; Wang QZ; Liang H; Katar A; Wang LJ
    Med Sci Monit; 2015 May; 21():1313-8. PubMed ID: 25950148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
    Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
    BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from high prevalence tuberculosis states in Mexico.
    Juarez-Eusebio DM; Munro-Rojas D; Muñiz-Salazar R; Laniado-Laborín R; Martinez-Guarneros JA; Flores-López CA; Zenteno-Cuevas R
    Infect Genet Evol; 2017 Nov; 55():384-391. PubMed ID: 27637930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redefining MDR-TB: Comparison of Mycobacterium tuberculosis clinical isolates from Russia and Taiwan.
    Jou R; Lee WT; Kulagina EV; Weng JY; Isakova AI; Lin WH; Antonova OV; Wu MH; Arslanbaeva LR; Tasi HY; Nosova EY; Zimenkov DV
    Infect Genet Evol; 2019 Aug; 72():141-146. PubMed ID: 30593924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of next-generation sequencing to detect variants of drug-resistant Mycobacterium tuberculosis: genotype-phenotype correlation.
    Ko DH; Lee EJ; Lee SK; Kim HS; Shin SY; Hyun J; Kim JS; Song W; Kim HS
    Ann Clin Microbiol Antimicrob; 2019 Jan; 18(1):2. PubMed ID: 30606210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First insights into circulating XDR and pre-XDR Mycobacterium tuberculosis in Southern Brazil.
    Salvato RS; Costa ERD; Reis AJ; Schiefelbein SH; Halon ML; Barcellos RB; Unis G; Dias CF; Viveiros M; Portugal I; da Silva PEA; Kritski AL; Perdigão J; Rossetti MLR
    Infect Genet Evol; 2020 Mar; 78():104127. PubMed ID: 31783187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance and characterization of drug-resistant
    Imperiale BR; Di Giulio ÁB; Mancino MB; Zumárraga MJ; Morcillo NS
    Int J Mycobacteriol; 2019; 8(3):223-228. PubMed ID: 31512597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
    Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
    Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First genetic characterisation of multidrug-resistant Mycobacterium tuberculosis isolates from Algeria.
    Bouziane F; Allem R; Sebaihia M; Kumanski S; Mougari F; Sougakoff W; Raskine L; Yala D; Cambau E;
    J Glob Antimicrob Resist; 2019 Dec; 19():301-307. PubMed ID: 31100498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quadruple-first line drug resistance in Mycobacterium tuberculosis in Vietnam: What can we learn from genes?
    Nguyen HQ; Nguyen NV; Contamin L; Tran THT; Vu TT; Nguyen HV; Nguyen NLT; Nguyen ST; Dang AD; Bañuls AL; Nguyen VAT
    Infect Genet Evol; 2017 Jun; 50():55-61. PubMed ID: 28214557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated from south-central in China.
    Yu XL; Wen ZL; Chen GZ; Li R; Ding BB; Yao YF; Li Y; Wu H; Guo XK; Wang HH; Zhang SL
    J Antibiot (Tokyo); 2014 Apr; 67(4):291-7. PubMed ID: 24326341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015.
    Merker M; Nikolaevskaya E; Kohl TA; Molina-Moya B; Pavlovska O; Brännberg P; Dudnyk A; Stokich V; Barilar I; Marynova I; Filipova T; Prat C; Sjöstedt A; Dominguez J; Rzhepishevska O; Niemann S
    Emerg Infect Dis; 2020 Mar; 26(3):481-490. PubMed ID: 32091369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from São Paulo, Brazil.
    Matsui T; Pinhata JMW; Rabello MCDS; Brandão AP; Ferrazoli L; Leão SC; Viana-Niero C; Oliveira RS
    Mem Inst Oswaldo Cruz; 2020; 115():e200055. PubMed ID: 32401997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview.
    Silva C; Perdigão J; Jordão L; Portugal I
    Int J Antimicrob Agents; 2014 Dec; 44(6):546-51. PubMed ID: 25270633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
    Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
    PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Jagielski T; Bakuła Z; Roeske K; Kamiński M; Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J
    J Antimicrob Chemother; 2014 Sep; 69(9):2369-75. PubMed ID: 24855126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.